Beijing Succeeder Technology Inc.
SHH: 688338.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Hai Wang
- Employees
- 296
- Headquarters
- Beijing, China
- IPO year
- 2020
- Market cap
- CN¥3.1B
- Website
- https://www.succeeder.com.cn
Loading 688338…
Loading profile data…Frequently asked questions about 688338
What does Beijing Succeeder Technology Inc. (688338.SS) do?
Beijing Succeeder Technology Inc. engages in the research and development, manufacture, and sale of in-vitro diagnostic products in China and internationally. Its products include coagulation analyzers and reagents, blood rheology analyzers, ESR analyzers, and platelet aggregation analyzers. The company was founded in 2003 and is headquartered i...
Where does 688338.SS trade?
Beijing Succeeder Technology Inc. (688338.SS) trades on the Shanghai Stock Exchange.
What sector is 688338.SS in?
Beijing Succeeder Technology Inc. (688338.SS) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Beijing Succeeder Technology Inc.?
Hai Wang is the chief executive officer of Beijing Succeeder Technology Inc. (688338.SS).
Where is Beijing Succeeder Technology Inc. headquartered?
Beijing Succeeder Technology Inc. is headquartered in China.
Does 688338.SS pay a dividend?
Yes — Beijing Succeeder Technology Inc. (688338.SS) paid a trailing twelve-month dividend of CNY 0.33 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 688338.SS go public?
Beijing Succeeder Technology Inc. (688338.SS) completed its initial public offering in 2020.